According to the National Institutes of Health, CME or Continuing Medical Education, consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession.
The IMF and Medscape bring you a series of videos for myeloma practitioners to earn such CME credits. This series includes:

This educational activity aims to equip healthcare professionals, particularly nurses, with up-to-date knowledge and practical strategies for managing patients with multiple myeloma. It covers new and emerging therapies such as CELMoDs®, CAR T-cell therapy, and bispecific antibodies, emphasizing adverse event management and patient education. The importance of therapy sequencing, including multidrug regimens and bridging therapy, is discussed alongside strategies to achieve deep responses through treatments like ASCT and maintenance therapy. The session also addresses health equity issues and advocates for shared decision-making between patients, caregivers, and healthcare providers throughout the treatment journey.
1.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Valid for credit through: 12/31/24

Authored by Elaine Wheat Dawson, PsyD; Rebecca Rooney, PhD; Urvi A. Shah, MD; and IMF Vice President of Support Groups Robin Tuoh, this activity is intended for hematology/oncology specialists, nurses, and nurse practitioners.
The goal of this activity is for learners to better recognize psychological burdens experienced by patients and care partners and to improve the efficacy of communication regarding unique stressors, prognosis understanding, and available supports for patients and their care partners following a diagnosis of multiple myeloma (MM).
CME / ABIM MOC / CE Credits are valid through December 29, 2024.